1
|
Silva Jungles de Carvalho LÂ, Oya-Silva LF, Perussolo MC, de Oliveira Guaita G, Moreira Brito JC, Evans AA, Prodocimo MM, Cestari MM, Bragah TT, Silva deAssis HC. Experimentally exposed toxic effects of long-term exposure to environmentally relevant concentrations of CIP in males and females of the silver catfish Rhamdia quelen. Chemosphere 2023:139216. [PMID: 37321459 DOI: 10.1016/j.chemosphere.2023.139216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/25/2023] [Revised: 05/17/2023] [Accepted: 06/12/2023] [Indexed: 06/17/2023]
Abstract
Ciprofloxacin (CIP) is an antibiotic commonly used in human and veterinary medicine. It is present in the aquatic environment, but we still know very little about its effect on non-targeted organisms. This study aimed to evaluate the effects of long-term exposure to environmental CIP concentrations (1, 10, and 100 μg.L-1) in males and females of Rhamdia quelen. After 28 days of exposure, we collected the blood for the analysis of hematological and genotoxic biomarkers. Additionally, we measured 17 β-estradiol and 11 keto-testosterone levels. After the euthanasia, we collected the brain and the hypothalamus to analyze acetylcholinesterase (AChE) activity and neurotransmitters, respectively. The liver and gonads were assessed for biochemical, genotoxic, and histopathological biomarkers. At 100 μg.L-1 CIP, we observed genotoxicity in the blood, nuclear morphological changes, apoptosis, leukopenia, and a reduction of AChE in the brain. In the liver was observed oxidative stress and apoptosis. At 10 μg.L-1 CIP, leukopenia, morphological changes, and apoptosis were presented in the blood and a reduction of AChE in the brain. Apoptosis, leukocyte infiltration, steatosis, and necrosis occurred in the liver. Even at the lowest concentration (1 μg.L-1), adverse effects such as erythrocyte and liver genotoxicity, hepatocyte apoptosis, oxidative stress, and a decrease in somatic indexes were observed. The results showed the importance of monitoring CIP concentrations in the aquatic environment that cause sublethal effects on fish.
Collapse
Affiliation(s)
| | - Laís Fernanda Oya-Silva
- Department of Genetics, Federal University of Paraná, PO Box 19071, 81530-980, Curitiba, PR, Brazil
| | - Maiara Carolina Perussolo
- Pelé Pequeno Principe Research Institute, 80.250-200, Curitiba, PR, Parana, Brazil; Department of Pharmacology, Federal University of Paraná, PO Box 19031, 81530-980, Curitiba, PR, Brazil
| | - Gisele de Oliveira Guaita
- Department of Pharmacology, Federal University of Paraná, PO Box 19031, 81530-980, Curitiba, PR, Brazil
| | | | - Allan Arnold Evans
- Department of Pharmacology, Federal University of Paraná, PO Box 19031, 81530-980, Curitiba, PR, Brazil; School of Medicine, Pequeno Principe Faculty, 80.230-020, Curitiba, PR, Brazil
| | - Maritana Mela Prodocimo
- Department of Cell Biology, Federal University of Paraná, PO Box 19031, 81530-980, Curitiba, PR, Brazil
| | - Marta Margarete Cestari
- Department of Genetics, Federal University of Paraná, PO Box 19071, 81530-980, Curitiba, PR, Brazil
| | - Tarcio Teodoro Bragah
- Department of Pathology, Federal University of Paraná, Curitiba, Brazil; Biosciences and Biotechnology Graduation Program, Instituto Carlos Chagas (ICC), Fiocruz, Curitiba, PR, Brazil
| | - Helena Cristina Silva deAssis
- Ecology and Conservation Program Post-Graduation, Federal University of Paraná, PO Box 19031, 81531-980, Curitiba, PR, Brazil; Ezequiel Dias Foundation, 30510-010, Belo Horizonte, MG, Brazil.
| |
Collapse
|
2
|
Evans AA, Jesus CHA, Martins LL, Fukuyama AH, Gasparin AT, Crippa JA, Zuardi AW, Hallak JEC, Genaro K, de Castro Junior CJ, Zanoveli JM, Cunha JMD. Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis. Cannabis Cannabinoid Res 2023. [PMID: 37205869 DOI: 10.1089/can.2021.0242] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/21/2023] Open
Abstract
Introduction: Diabetic neuropathies are the most prevalent chronic complications of diabetes, characterized by pain and substantial morbidity. Although many drugs have been approved for the treatment of this type of pain, including gabapentin, tramadol (TMD), and classical opioids, it is common to report short-term results or potentially severe side effects. TMD, recommended as a second-line treatment can lead to unwanted side effects. Cannabidiol (CBD) has been gaining attention recently due to its therapeutic properties, including pain management. This study aimed to characterize the pharmacological interaction between CBD and TMD over the mechanical allodynia associated with experimental diabetes using isobolographic analysis. Materials and Methods: After diabetes induction by streptozotocin (STZ), diabetic rats were systemically treated with CBD or TMD alone or in combination (doses calculated based on linear regression of effective dose 40% [ED40]) and had the mechanical threshold evaluated using the electronic Von Frey apparatus. Both experimental and theoretical additive ED40 values (Zmix and Zadd, respectively) were determined for the combination of CBD plus TMD in this model. Results: Acute treatment with CBD (3 or 10 mg/kg) or TMD (2.5, 5, 10, or 20 mg/kg) alone or in combination (0.38+1.65 or 1.14+4.95 mg/kg) significantly improved the mechanical allodynia in STZ-diabetic rats. Isobolographic analysis revealed that experimental ED40 of the combination (Zmix) was 1.9 mg/kg (95% confidence interval [CI]=1.2-2.9) and did not differ from the theoretical additive ED40 2.0 mg/kg (95% CI=1.5-2.8; Zadd), suggesting an additive antinociceptive effect in this model. Conclusions: Using an isobolographic analysis, these results provide evidence of additive pharmacological interaction between CBD and TMD over the neuropathic pain associated with experimental diabetes induced by STZ.
Collapse
Affiliation(s)
- Allan Arnold Evans
- Laboratory of Pharmacology of Pain, Department of Pharmacology, Federal University of Paraná, Curitiba, Paraná, Brazil
| | - Carlos Henrique Alves Jesus
- Laboratory of Pharmacology of Pain, Department of Pharmacology, Federal University of Paraná, Curitiba, Paraná, Brazil
| | - Lucas Latchuk Martins
- Laboratory of Pharmacology of Pain, Department of Pharmacology, Federal University of Paraná, Curitiba, Paraná, Brazil
| | - Alisson Hideki Fukuyama
- Laboratory of Pharmacology of Pain, Department of Pharmacology, Federal University of Paraná, Curitiba, Paraná, Brazil
| | - Alexia Thamara Gasparin
- Laboratory of Pharmacology of Pain, Department of Pharmacology, Federal University of Paraná, Curitiba, Paraná, Brazil
| | - José Alexandre Crippa
- National Institute for Translational Medicine (INCT-TM, CNPq), Ribeirão Preto, São Paulo, Brazil
- Department of Neuroscience and Behavior, University of São Paulo, USP, Ribeirão Preto, São Paulo, Brazil
| | - Antonio Waldo Zuardi
- National Institute for Translational Medicine (INCT-TM, CNPq), Ribeirão Preto, São Paulo, Brazil
- Department of Neuroscience and Behavior, University of São Paulo, USP, Ribeirão Preto, São Paulo, Brazil
| | - Jaime Eduardo Cecílio Hallak
- National Institute for Translational Medicine (INCT-TM, CNPq), Ribeirão Preto, São Paulo, Brazil
- Department of Neuroscience and Behavior, University of São Paulo, USP, Ribeirão Preto, São Paulo, Brazil
| | - Karina Genaro
- Department of Anesthesiology, University of California, Irvine, California, USA
| | | | - Janaina Menezes Zanoveli
- Laboratory of Pharmacology of Pain, Department of Pharmacology, Federal University of Paraná, Curitiba, Paraná, Brazil
| | - Joice Maria da Cunha
- Laboratory of Pharmacology of Pain, Department of Pharmacology, Federal University of Paraná, Curitiba, Paraná, Brazil
| |
Collapse
|
3
|
Martin BM, Evans AA, de Carvalho DS, Shimakura SE. Clinical outcomes of dengue virus infection in pregnant and non-pregnant women of reproductive age: a retrospective cohort study from 2016 to 2019 in Paraná, Brazil. BMC Infect Dis 2022; 22:5. [PMID: 34983412 PMCID: PMC8725439 DOI: 10.1186/s12879-021-06985-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Accepted: 12/15/2021] [Indexed: 12/02/2022] Open
Abstract
BACKGROUND The increasing number of dengue cases worldwide implies a greater exposure of at-risk groups, such as pregnant women. DENV infection during pregnancy has been increasingly associated with unfavorable outcomes, but the evolution of the disease and its clinical outcomes remain unclear. The objective of this study was to characterize dengue cases in reproductive aged women by comparing the development of the disease in pregnant and non-pregnant women. METHODS A population based retrospective cohort study that used data reported in the Brazilian Mandatory Notifiable Diseases Information System from 2016 to 2019 in Paraná, Brazil. We compared sociodemographic, clinical, and laboratory variables between pregnant and non-pregnant women. Hospitalization and disease severity classification (Dengue, Dengue with warning signs, Severe Dengue) were considered outcome variables. RESULTS The two groups had differences in the year of notification, age distribution, and region of residence. Laboratory investigation was more frequent among pregnant women, and DENV-2 prevailed in both groups. The risks of hospitalization and development of Severe Dengue were higher in pregnant women. There were no deaths observed among pregnant women. CONCLUSION This study identified pregnancy as a risk factor for an increase in the severity of DENV infection. It reinforces the importance of identifying early signs of complication, close monitoring, and adequate treatment for pregnant women.
Collapse
|
4
|
Bliss JM, Robison LE, Webster-Smith MF, Emson MA, Kilburn LS, Smith IE, Robertson J, Dowsett M, Bundred NJ, Cameron DA, Vidya R, Horgan K, Evans AA, Kokan JS, Pinhel I, A'Hern R. OT2-03-04: A Trial Model for the Future in the Search for Personalised Medicine – The UK POETIC and EPHOS-B Perioperative Trials Experience. Cancer Res 2011. [DOI: 10.1158/0008-5472.sabcs11-ot2-03-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background
Perioperative therapy offers the opportunity to measure biological response to treatment in the primary tumor in early breast cancer (EBC), enhancing prospects for personalised medicine. Perioperative trials form an expanding component of the UK national breast cancer trials portfolio. Unlike traditional neoadjuvant studies, activity dovetails around timelines for standard treatment with no planned delay to primary surgery. Tissue samples collected prior to randomisation (baseline) & again at surgery address key biological endpoints & are essential for perioperative studies.
Methods: As the UK's largest perioperative trial, POETIC (ER+ve postmenopausal EBC, +/− aromatase inhibitor therapy, biomarker & disease outcome) aims to recruit 4000 patients from 100+ centres.
EPHOS-B (HER2+ve EBC, +/− lapatinib or trastuzumab) focuses on biomarker endpoints & aims to recruit 250 patients. Barriers to recruitment included 1) integration of research protocols into busy breast surgical clinics, extending a clinical trials culture across a multidisciplinary breast diagnostic team, & ensuring appropriate GCP training, 2) satisfying requirements for storing research tissue, 3) complying with government cancer wait times, 4) obtaining biomarker results within required timelines 5) ensuring completeness & quality of tissue samples. Additional challenges for EPHOS-B include managing requirements for scheduling of oncological therapy (e.g. trastuzumab) in pre-operative setting, delivery of such therapy outside the randomising hospital & rapid access to cardiac screening before randomisation.
Results: The following strategies were developed to overcome barriers 1) increasing collaborative working at sites & adopting a pragmatic approach to type of tissue required. Centres choose to provide both FFPE tissue & tissue in RNA-later, or FFPE tissue only; 2) working with national regulators to agree interpretation of current legislation in designation of when tissue is “in transit” (enabling it to reside outside a tissue bank) & “research” tissue (where transfer to a tissue bank is required); 3) agreement with government that procedures integral to perioperative trials comply with cancer wait times; 4) promoting reorganisation of site processes for obtaining essential biomarker results; 5) pilot lab work to inform site guidance on tissue collection procedures to ensure quality of samples received. A tracking database allows completeness of tissue samples to be monitored. Work to improve timelines for HER2 testing in EPHOS-B is ongoing, & challenges of delivering anti-HER2 therapy in this setting have been addressed.
Conclusions: Assessment of biological response to therapy in the primary tumor in EBC within national trials is feasible. Many barriers faced by POETIC have been overcome, & with recruitment now 100+ patients per month, newer centres benefit from earlier experience. Lessons learnt in POETIC apply to EPHOS-B, allowing investigators to focus on resolving more challenging issues specific to that trial. In many centres both trials have been important drivers in improving timeliness of molecular testing & therefore benefited the patient pathway in general as well as securing high quality trial data.
Citation Information: Cancer Res 2011;71(24 Suppl):Abstract nr OT2-03-04.
Collapse
Affiliation(s)
- JM Bliss
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - LE Robison
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - MF Webster-Smith
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - MA Emson
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - LS Kilburn
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - IE Smith
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - J Robertson
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - M Dowsett
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - NJ Bundred
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - DA Cameron
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - R Vidya
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - K Horgan
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - AA Evans
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - JS Kokan
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - I Pinhel
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | - R A'Hern
- 1Institute of Cancer Research, Sutton, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nottingham University Hospitals, Nottingham, United Kingdom; Royal Marsden Hospital and Breakthrough Breast Cancer Centre, London, United Kingdom; Wythenshawe Hospital, Manchester, United Kingdom; Western General Hospital, Edinburgh, United Kingdom; Stafford Hospital, Stafford, United Kingdom; Leeds General Infirmary, Leeds, United Kingdom; Poole Hospital, Poole, United Kingdom; Macclesfield District General Hospital, Macclesfield, United Kingdom
| | | |
Collapse
|
5
|
Evans AA, Macdonald D. Using metrology in early prehistoric stone tool research: further work and a brief instrument comparison. Scanning 2011; 33:294-303. [PMID: 21997320 DOI: 10.1002/sca.20272] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/09/2011] [Accepted: 07/11/2011] [Indexed: 05/31/2023]
Abstract
Early prehistoric research aims to discover the activities of our ancestors and piece together the process of evolution and sociocultural development. A key element in this process is the study of stone tools, particularly how these tools functioned in prehistory. Currently, there are no established quantitative methods that address stone tool function. This article provides a summary of previous studies using metrological methods in stone tool research and details the use of laser scanning confocal microscopy to conduct areal surface analysis using three-dimensional data sets. Research to-date is preliminary but promising and shows that microscopic metrological approaches can provide a quantitative method to identify how stone tools were used. A limited comparison of two metrological systems is presented, the results of which highlight a need for caution and further investigation on the comparability of related data sets.
Collapse
Affiliation(s)
- A A Evans
- School of Life Sciences, University of Bradford, Bradford, United Kingdom.
| | | |
Collapse
|
6
|
Affiliation(s)
- C Cohen
- Hepatitis B FoundationDoylestown, PA
| | - A A Evans
- Hepatitis B FoundationDoylestown, PA,Drexel University School of Public HealthPhiladelphia, PA, USA
| | - W T London
- Fox Chase Cancer CenterPhiladelphia, PA, USA
| | - J Block
- Hepatitis B FoundationDoylestown, PA
| | - M Conti
- Hepatitis B FoundationDoylestown, PA
| | - T Block
- Hepatitis B FoundationDoylestown, PA,Drexel University College of MedicinePhiladelphia, PA, USA
| |
Collapse
|
7
|
Malinow MR, Duell PB, Williams MA, Kruger WD, Evans AA, Anderson PH, Block PC, Hess DL, Upson BM, Graf EE, Irvin-Jones A, Wang L. Short-term folic acid supplementation induces variable and paradoxical changes in plasma homocyst(e)ine concentrations. Lipids 2002; 36 Suppl:S27-32. [PMID: 11837988 DOI: 10.1007/s11745-001-0678-8] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Folic acid is presently the mainstay of treatment for most subjects with elevated plasma homocyst(e)ine concentrations [Plasma or serum homocyst(e)ine, or total homocysteine, refers to the sum of the sulfhydryl amino acid homocysteine and the homocysteinyl moieties of the disulfides homocystine and homocystein-cysteine, whether free or bound to plasma proteins.] Changes in homocyst(e)ine in response to folic acid supplementation are characterized by considerable interindividual variation. The purpose of this study was to identify factors that contribute to heterogeneity in short-term responses to folic acid supplementation. The effects of folic acid supplementation (1 or 2 mg per day) for 3 wk on plasma homocyst(e)ine concentrations were assessed in 304 men and women. Overall, folic acid supplementation increased mean plasma folate 31.5 +/- 98.0 nmol/L and decreased mean plasma homocyst(e)ine concentrations 1.2 +/- 2.4 micromol/L. There was evidence of substantial interindividual variation in the homocyst(e)ine response from -18.5 to +7.1 micromol/L, including an increase in homocyst(e)ine in 20% of subjects (mean increase 1.5 +/- 1.4 micromol/L). Basal homocyst(e)ine, age, male gender, cigarette smoking, use of multivitamins, methylene tetrahydrofolate reductase, and cystathionine beta-synthase polymorphisms accounted for 47.6% of the interindividual variability in the change in homocyst(e)ine after folic acid supplementation, but about 50% of variability in response to folic acid was not explained by the variables we studied.
Collapse
Affiliation(s)
- M R Malinow
- Department of Pathobiology and Immunology, Oregon Regional Primate Research Center, Beaverton 97006, USA.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Abstract
Specific binding sites for [125I]beta-endorphin and the delta1-opioid [3H][D-pen(2), D-pen(5)]enkephalin (DPDPE) were quantified using autoradiography in soleus and extensor digitorum longus (EDL) muscles of lean and obese-diabetic (ob/ob) mice. The density of binding was significantly higher in obese-diabetic than lean mice. The uptake of 2-deoxy-D-[1-3H]deoxyglucose, a nonmetabolized glucose analogue, into isolated soleus and EDL muscles was stimulated by beta-endorphin, beta-endorphin 1-27, and DPDPE, but not by the delta2-opioid deltorphin II. Both beta-endorphin and DPDPE stimulated deoxyglucose uptake in obese-diabetic mice. Thus, glucose transport in skeletal muscle may be partly mediated via delta1-opioid receptors. The increased receptor density in obese-diabetic mice may be an adaptive response.
Collapse
Affiliation(s)
- A A Evans
- Department of Physiology, Medical School, University of Birmingham, Birmingham, UK
| | | | | | | | | |
Collapse
|
9
|
Abstract
In contrast to men, the incidence of lung cancer among women has increased over the past decade. The basis for this increase among female smokers remains unknown. Surgical patients with a diagnosis of lung cancer and control subjects without a history of malignancy completed a smoking questionnaire and donated a blood sample. DNA was extracted from peripheral mononuclear cells and genotyped for polymorphisms in cytochrome P450 1A1 (CYP1A1) (exon 7) and glutathione S-transferase M1 (GSTM1) (null). No gender differences in either age at diagnosis or histological subtype were observed among lung cancer patients. In both patients (n = 180) and controls (n = 163), females smoked significantly less than males. The pack-year history associated with adenocarcinoma was smaller than that for squamous cell carcinoma. No significant association was observed between the GSTM1 null genotype and cancer risk. However, women had a larger cancer risk than men (odds ratio 4.98 vs. 1.37) if they possessed the mutant CYP1A1 genotype. Female cancer patients were significantly more likely than female controls to have both the CYP1A1 mutation and GSTM1 null genotype. The combined variant genotypes conferred an odds ratio of 6.54 for lung cancer in women versus 2.36 for men, independent of age or smoking history. These data suggest that polymorphisms in CYP1A1 and GSTM1 contribute to the increased risk of females for lung cancer.
Collapse
Affiliation(s)
- C M Dresler
- Department of Surgical Onccology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
| | | | | | | | | | | |
Collapse
|
10
|
Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, Block PC, Hess DL, Graf EE, Upson B. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab 2000; 70:53-60. [PMID: 10833331 DOI: 10.1006/mgme.2000.2993] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Elevated total plasma homocysteine (tHcy) is an established risk factor for the development of vascular disease and neural tube defects. Total homocysteine levels can be lowered by folic acid supplements but individual response is highly variable. In this case-control study, involving 142 coronary artery disease (CAD) patients and 102 controls, we have typed six genetic polymorphisms in three homocysteine metabolizing genes and examined their relationship to the incidence of CAD, tHcy levels, and lowering of tHcy levels in response to folic acid supplementation. We found that two single nucleotide polymorphisms in the cystathionine beta synthase (CBS) gene, 699C --> T and 1080T --> C, are associated with decreased risk of CAD and increased responsiveness to the tHcy lowering effects of folic acid. Individuals homozygous for 699T were significantly underrepresented in CAD patients as compared to controls (4.9% vs 17.3%, P = 0.0015), as were individuals homozygous for the 1080C (29.6% vs 44.2%, P = 0.018). Additionally, 699T and 1080C homozygous individuals were the most responsive to folate supplementation. 699T homozygotes lowered tHcy levels 13.6% on average, compared to 4.8% lowering in 699C homozygotes (P = 0.009), while 1080C homozygotes lowered 12.9% compared to just 2.7% for 1080T homozygotes (P = 0.005). The two polymorphisms in CBS are third codon changes and would not be predicted to affect the underlying protein. However, there is strong linkage disequilibrium between these two positions, suggesting that they may also be linked to other as yet unidentified polymorphisms within the CBS gene. These observations suggest that specific CBS alleles are a risk factor for the development of vascular disease and that genetic information could be predictive of individual response to folic acid supplementation.
Collapse
Affiliation(s)
- W D Kruger
- Division of Population Science, Fox Chase Cancer Center, Philadelphia, PA, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
|
12
|
Barratt BI, Evans AA, Stoltz DB, Vinson SB, Easingwood R. Virus-like particles in the ovaries of microctonus aethiopoides loan (Hymenoptera: braconidae), a parasitoid of adult weevils (Coleoptera: curculionidae). J Invertebr Pathol 1999; 73:182-8. [PMID: 10066398 DOI: 10.1006/jipa.1998.4826] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The morphology of the female reproductive system of Microctonus aethiopoides is described and illustrated, and an ultrastructural examination of the ovaries was carried out. Virus-like particles (VLPs) were initially found in the ovarial epithelial cells of females from pre-adult emergence from the pupal cocoon until at least 5 days after emergence. The particles assembled in the nucleus of the epithelial cells, apparently being synthesized de novo in association with a putative virogenic stroma, and they moved into the lumen of the ovarioles surrounding the developing eggs. VLPs were also found in some other cells in both male and female M. aethiopoides. VLPs have not been found in M. hyperodae or the New Zealand native species M. zealandicus. The function of the VLP and its possible role in potential parasitoid host range determination are discussed. Copyright 1999 Academic Press.
Collapse
Affiliation(s)
- BI Barratt
- New Zealand Pastoral Agriculture Research Institute Ltd., Invermay Agricultural Centre, Mosgiel, New Zealand
| | | | | | | | | |
Collapse
|
13
|
Evans AA, O'Connell AP, Pugh JC, Mason WS, Shen FM, Chen GC, Lin WY, Dia A, M'Boup S, Dramé B, London WT. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 1998; 7:559-65. [PMID: 9681522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
The risk of hepatocellular carcinoma (HCC) varies significantly among hepatitis B virus (HBV) carriers from different geographic regions. We compared serological markers of HBV infection in adult male carriers from Haimen City, China and Senegal, West Africa, where the prevalence of chronic infection is similar. HCC mortality among HBV carriers is much higher in Haimen City than it is in Senegal (age-standardized rate, 878 versus 68 per l0(5) person-years). A dramatic difference was observed when HBV DNA levels in serum were assessed among carriers by Southern blot. In the Senegalese group (n = 289), 14.5% were HBV DNA positive by Southern blot in their 20s, and this percentage declined in each subsequent decade of age to 3.3, 2.9, and 0% thereafter. In the Chinese group (n = 285), a higher prevalence of HBV DNA positivity and a less consistent reduction were seen; 29.4% were positive in their 20s, and 30.2, 23.6, and 20.6%, respectively, were positive in each subsequent decade of age. Among 102 male Asian-American HBV carriers, the prevalence of HBV DNA positivity was intermediate between the Chinese and Senegalese populations (36.8, 10.7, 3.0, and 4.6% in each subsequent decade of age). Viral titers were similar among those who were HBV DNA positive in all three populations [median value, 10(7) virions/ml (range, 10(6)-10(9) virions/ml)]. The presence of HBV DNA in serum was positively associated with serum glutathione S-transferase, a marker of liver damage. These findings suggest that the more prolonged maintenance of productive virus infection in the Chinese carriers compared with the Senegalese carriers may explain their higher risk of HCC. This profound difference in the natural history of chronic infection may be due to earlier age of infection in China or to as yet unknown environmental or genetic factors.
Collapse
Affiliation(s)
- A A Evans
- Division of Population Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Evans AA, Fine MK, London WT. Do Asian HBV carriers differ from non-Asian carriers? Lancet 1998; 351:1285-6. [PMID: 9643771 DOI: 10.1016/s0140-6736(05)79349-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
15
|
Abstract
The uptake of 2-[3H]deoxyglucose, a non-metabolisable derivative of glucose, was studied in resting and contracting muscle. An isolated phrenic nerve/hemidiaphragm preparation of the mouse was used, and contractions of the muscle were elicited by electrical stimulation of the nerve. beta-Endorphin stimulated the uptake of 2-deoxyglucose in resting diaphragm muscle. The rate of uptake in the presence of the optimum concentration of beta-endorphin was similar to that in the presence of the optimum concentration of insulin over the short incubation period. beta-Endorphin also stimulated the uptake of 2-deoxyglucose in contracting muscle, but the optimum concentration of the peptide for this effect was three orders of magnitude lower than in resting muscle. The optimum concentration for insulin, however, was similar in resting and contracting muscle. An analogue of the C-terminal tetrapeptide of beta-endorphin also stimulated 2-deoxyglucose uptake, but this peptide was equally efficacious in resting and contracting muscle. It is suggested that beta-endorphin, which is released into the circulation during exercise, may have a hormonal action to increase the uptake of glucose during muscular activity. This peptide or its metabolites may be partly responsible for the insulin-independent uptake of glucose during exercise.
Collapse
Affiliation(s)
- A A Evans
- Department of Physiology, Medical School, University of Birmingham, UK
| | | | | |
Collapse
|
16
|
Evans AA, Fine M, London WT. Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: implications for interferon therapy. J Infect Dis 1997; 176:845-50. [PMID: 9333140 DOI: 10.1086/516538] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
This study compared rates of spontaneous hepatitis B e antigen (HBeAg)-positive to -negative seroconversion in chronic carriers of hepatitis B virus (HBV) with rates reported during interferon-alpha therapy. Four hundred fifty-four Asian-American HBeAg-positive HBV carriers, followed for 1-10 years, were tested approximately every 6 months for HBeAg. Patients with alanine aminotransferase levels > or = 50 IU/mL at entry had 1067.3 seroconversions/10(5) person-months in the 5- to 19-year age group, 1753.3 in the 20- to 34-year group, and 1257.2 in the 35- to 50-year group. Published data indicate that 30% of children and 33% of adults seroconvert during interferon-alpha treatment and follow-up. In our study population, spontaneous seroconversion occurred in 15% of children (95% confidence interval [CI], 8%-27%), 23% of adults 20-34 years (95% CI, 15%-34%), and 17% of adults 35-50 years (95% CI, 10%-28%) during the same interval. The high rate of spontaneous seroconversion should be weighed in decisions to treat HBV carriers with interferon-alpha.
Collapse
Affiliation(s)
- A A Evans
- Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
| | | | | |
Collapse
|
17
|
Zhou T, Evans AA, London WT, Xia X, Zou H, Shen F, Clapper ML. Glutathione S-transferase expression in hepatitis B virus-associated human hepatocellular carcinogenesis. Cancer Res 1997; 57:2749-53. [PMID: 9205086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Hepatitis B virus (HBV) and aflatoxin B1 represent the main risk factors for the development of hepatocellular carcinoma (HCC) in areas endemic for liver cancer. The glutathione S-transferases (GSTs) are a family of Phase II detoxification enzymes that catalyze the conjugation of a wide variety of endogenous and exogenous toxins, including aflatoxin B1, with glutathione. This study characterizes the GST isoenzyme composition (alpha, mu, and pi) of both HBV-infected normal hepatic tissues and HCCs. Analysis of matched pairs of hepatic tissue (normal and tumor) from 32 HCC patients indicated that total GST activity was significantly higher in normal tissues than in tumor tissues, although the percentage of samples expressing GST alpha and pi was equivalent. GST mu was detected by Western blot in the normal tissue from 87.5% of the subjects possessing the GST M1 gene but only 28.6% of the corresponding tumor tissues. The GST activity of normal tissue from GST M1 null patients was significantly decreased as compared to that of subjects possessing the GST M1 gene (264.6 and 422.2 nmol/min/mg, respectively; P = 0.005). GST pi appeared to be overexpressed in the normal tissue of GST M1 null patients, a potential compensatory effect. Patients positive for HBV DNA had significantly lower GST activity than those who were HBV negative (302.1 versus 450.0 nmol/min/mg, respectively; P = 0.02). These results suggest that cellular protection within the human liver is compromised by HBV infection and further decreased during hepatocellular tumorigenesis.
Collapse
Affiliation(s)
- T Zhou
- Division of Population Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
| | | | | | | | | | | | | |
Collapse
|
18
|
Abstract
Somatostatin analogues may be useful novel agents in the systemic treatment of advanced colorectal cancer, as somatostatin inhibits proliferation in a wide variety of cell types. Here, we report the expression profiles of somatostatin receptor mRNAs in 32 pairs of malignant and normal colonic epithelia. Receptor subtype 2 (hSSTR2) mRNA was detected throughout nearly 90% of both malignant and normal tissue by reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization. Subtype 5 (hSSTR5) mRNA was detected in 46% and 45% of tumour and mucosal samples respectively, but in 75% (9/12) of early-stage tumours (tubulovillous adenomas, Dukes' A and B) compared with 31% (5/16) of late-stage tumours (Dukes' C and 'D' tumours), 0.05>P>0.025 (chi2 with Yates' correction). There was also reduced expression of hSSTR5 in samples of metastatic tumour (11%, 1/9) compared with all tumour samples (56%, 18/32) 0.025>P>0.01 (chi2 with Yates' correction). Other hSSTRs (1, 3 and 4) were expressed infrequently. Thus, hSSTR2 expression is retained after malignant transformation in colonic epithelium and, although it may potentially be a target for antiproliferative therapy, its ubiquitous expression militates against this. hSSTR5 warrants investigation as a tumour suppressor.
Collapse
Affiliation(s)
- S A Laws
- University Department of Surgery, Southampton General Hospital, Hampshire, UK
| | | | | | | | | |
Collapse
|
19
|
Abstract
Somatostatin is a widely distributed inhibitory peptide with growth-inhibitory effects in several human tumours, including breast cancer, raising the possibility that it may have therapeutic potential. The effects of somatostatin are mediated via a family of cell-surface receptors that differ in their tissue distribution, pharmacological properties and intracellular response mediators, suggesting that they mediate different functions of the peptide. We have analysed the expression of somatostatin receptor subtype (SSTR1-5) mRNA in normal and malignant breast tissue. Receptor expression was analysed by reverse transcription-polymerase chain reaction (RT-PCR) using receptor subtype-specific primers and by in situ hybridization (ISH) with riboprobes synthesized by in vitro transcription of cloned PCR products. A total of 51 breast carcinomas, 36 samples of matched normal tissue, two axillary node metastases and eight normal/benign breast tissue samples were analysed. SSTR2 expression was ubiquitous in both normal and malignant breast tissue. Expression of SSTR5 was detected in approximately one-third of tumour and normal tissue, but fewer than 13% of all tissues expressed SSTR1, 3 and 4. These data suggest that SSTR2 gene expression is ubiquitous in breast cancer. Although this is unlikely to have diagnostic or prognostic significance, SSTR2-specific somatostatin analogues may have therapeutic potential in breast cancer.
Collapse
Affiliation(s)
- A A Evans
- Academic Department of Surgery, Southampton General Hospital, UK
| | | | | | | | | | | |
Collapse
|
20
|
Anderson EM, Jones DR, Liu DT, Evans AA. Gestational age and cell viability determine the effect of frozen storage on human fetal hematopoietic progenitor cell preparations. Fetal Diagn Ther 1996; 11:427-32. [PMID: 9115632 DOI: 10.1159/000264360] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
We have assessed hematopoietic progenitor cell preparations (including CD34-positive stem cells) obtained from human fetal liver at 6-17 weeks of gestational age for total cell numbers, viability and the ability to tolerate (frozen) storage. Hematopoietic cell preparations obtained from the 16-to 17-week gestational age range had the highest total cell count and the greatest proportion of CD34-positive stem cells. However, these preparations were insufficiently robust to withstand the freeze/thaw protocol required. Cells obtained from the 13- to 15-week gestational age range showed optimal post-thaw viability and it is suggested that these cell preparations are the most applicable for in utero transplantation.
Collapse
Affiliation(s)
- E M Anderson
- Department of Immunology, Queens Medical Centre, Nottingham, UK
| | | | | | | |
Collapse
|
21
|
London WT, Evans AA. The epidemiology of hepatitis viruses B, C, and D. Clin Lab Med 1996; 16:251-71. [PMID: 8792071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Chronic viral hepatitis is caused mainly by chronic infection with hepatitis viruses B (HBV), C (HCV), or delta (HDV). Persons chronically infected with one or more of these viruses may develop chronic progressive hepatitis, cirrhosis, and liver failure. In addition, chronic HBV and HCV infections are major causal risk factors for hepatocellular carcinoma. Alcohol consumption accelerates the development of chronic liver disease among HCV-infected individuals and may have similar effects on persons chronically infected with HBV alone or HBV and HDV, but the reported studies are inconsistent.
Collapse
Affiliation(s)
- W T London
- Division of Population Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
| | | |
Collapse
|
22
|
|
23
|
Abstract
Autoradiography was used to demonstrate beta-endorphin and delta-opioid receptors in muscles of normal and obese-diabetic mice. The density of the receptors was significantly higher in the obese-diabetic mice. In both normal and diabetic mice, glycolytic and oxidative fibers exhibited the beta-endorphin receptors. However, a significantly greater density of beta-endorphin receptors was observed in the extensor digitorum longus muscles than in the soleus muscles in the diabetic mice. In normal muscles the beta-endorphin receptors were largely restricted to regions where endplates were present, but in the obese-diabetic mice they were densely distributed along the length of the muscle fibers.
Collapse
MESH Headings
- Acetylcholinesterase/analysis
- Animals
- Diabetes Mellitus/metabolism
- Diabetes Mellitus, Type 2/metabolism
- Female
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Obese
- Motor Endplate/metabolism
- Muscle Fibers, Skeletal/metabolism
- Muscle, Skeletal/cytology
- Muscle, Skeletal/metabolism
- Muscle, Skeletal/pathology
- Obesity
- Receptors, Opioid/metabolism
- Receptors, Opioid, delta/metabolism
- Reference Values
Collapse
Affiliation(s)
- A A Evans
- Department of Physiology, Medical School, University of Birmingham, Edgbaston, UK
| | | |
Collapse
|
24
|
Jones DR, Anderson EM, Evans AA, Liu DT. Long-term storage of human fetal haematopoietic progenitor cells and their subsequent reconstitution. Implications for in utero transplantation. Bone Marrow Transplant 1995; 16:297-301. [PMID: 7581151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Haematopoietic progenitor cells were isolated from human fetal liver, obtained between 6 and 15 weeks gestation. After preparation of a single cell suspension, the cells were stored using a stepwise freezing protocol; taking the cells from room temperature through -70 degrees C to liquid nitrogen. Viability (trypan blue exclusion), morphology (Leishman stain), identification of cell type (flow cytometry) and growth characteristics in semi-solid culture medium were assessed using the fresh cell suspension. We were able to confirm that the predominant cells in human fetal liver up to about 15 weeks gestation are those of the erythroid lineage. It was established that viability in excess of 75% was required to ensure adequate growth in culture after frozen storage and it was deemed important to ensure morphological integrity of the cell preparations. The colonies formed in culture were observed to be producing haemoglobin between 7 and 9 days after initial seeding. We have determined that cells can be stored in liquid nitrogen for up to 2 years without loss of (1) viability, (2) morphological features and (3) ability to form colonies and produce haemoglobin in culture. These findings offer encouragement for the implementation of a cell bank to support an in utero transplantation programme.
Collapse
Affiliation(s)
- D R Jones
- Department of Immunology, Queens Medical Centre, Nottingham, UK
| | | | | | | |
Collapse
|
25
|
London WT, Evans AA, McGlynn K, Buetow K, An P, Gao L, Lustbader E, Ross E, Chen G, Shen F. Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology 1995; 38:155-61. [PMID: 8682610 DOI: 10.1159/000150426] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
To identify specific environmental, viral, and genetic risk factors for hepatocellular carcinoma (HCC) and the interaction of such factors, we are conducting a prospective study in a high-incidence area of China. Questionnaires were completed and biosamples collected by 60,984 men ages 30-64 years, at study entry. Within 2.5 years, 183 deaths from HCC had occurred. Each HCC case was matched with 5 controls and compared for items on the questionnaire. In addition to chronic hepatitis B virus (HBV) infection, the significant risk factors were: occupation (peasant), corn consumption (in the 1970s), family history of HCC, and history of an episode of acute hepatitis as an adult. HBV, consumption of aflatoxins, a genetic factor, and possibly a second hepatitis virus infection contribute to the risk of HCC.
Collapse
Affiliation(s)
- W T London
- Fox Chase Cancer Center, Philadelphia, PA 19111, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Abstract
Autoradiography was used to study the opioid receptors in soleus and extensor digitorum longus (EDL) muscles from normal mice and mice with type II diabetes. Binding sites for [125I]beta-endorphin were present on the surface membranes in muscles from normal mice. The density of receptors was higher in muscles from obese diabetic mice. The specific delta-opioid ligands DPDPE and [D-Ala2]deltorphin-II inhibited the binding of [125I]beta-endorphin whereas mu and kappa agonists did not. Therefore, the opioid receptor present in skeletal muscle fibers of the mouse is of the delta subtype and the number of these receptors is increased in type II diabetes in the mouse.
Collapse
MESH Headings
- Analgesics/pharmacology
- Animals
- Autoradiography
- Binding, Competitive
- Cell Membrane/metabolism
- Diabetes Mellitus/genetics
- Diabetes Mellitus/metabolism
- Diabetes Mellitus, Type 2/metabolism
- Enkephalin, D-Penicillamine (2,5)-
- Enkephalins/pharmacology
- Iodine Radioisotopes
- Mice
- Mice, Obese
- Muscle, Skeletal/metabolism
- Obesity
- Oligopeptides/pharmacology
- Receptors, Opioid, delta/analysis
- Receptors, Opioid, delta/metabolism
- Reference Values
- beta-Endorphin/metabolism
Collapse
Affiliation(s)
- A A Evans
- Department of Physiology, Medical School, University of Birmingham, UK
| | | | | |
Collapse
|
27
|
Evans AA, Straker VF, Rainsbury RM. Breast reconstruction at a district general hospital. J R Soc Med 1993; 86:630-3. [PMID: 8258795 PMCID: PMC1294218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
Breast reconstruction is normally carried out by plastic surgeons, but the advent of permanent tissue expanders places post-mastectomy reconstruction within easy reach of the general surgeon. Nineteen patients underwent breast reconstruction between 1989 and 1991 using a subpectoral silicone-based, double lumen tissue expander. Assessment of results was by: (a) patient completed questionnaire; and (b) third party evaluation of standardized photographs. The mean operating time was 58 min (40-80 min) and mean hospital stay 3 days (2-7 days). Complications included one flap necrosis and one leaking injection port. Outpatient tissue expansion required an average of seven visits (4-11) and was completed in an average of 12 months (7-19). The injection port was subsequently removed under local anaesthetic as a day case. The fully dressed appearance following reconstruction was graded good or excellent by 100% of patients and in over 80% of third-party assessments. Equivalent figures for the appearance when wearing a bra were 93% and 60% and undressed 57% and 47%, respectively. All patients recommended the procedure but 25% found inflation uncomfortable. Subpectoral tissue expansion is a safe, cosmetically acceptable method of breast reconstruction which is associated with a high level of patient satisfaction.
Collapse
Affiliation(s)
- A A Evans
- Breast Unit, Royal Hampshire County Hospital, Winchester, UK
| | | | | |
Collapse
|
28
|
Abstract
When risk factors for an infectious disease are unknown, a method commonly employed is to investigate parallels with known infections (covariate infections). Data sets of value here are those for specified populations in which the seroprevalence of antibodies for multiple infections has been ascertained. The use of markers of covariate infections in multivariable analyses is problematic when the covariate infection is not itself an independent risk factor for the outcome of interest. In the performance of these analyses, the authors recommend the following strategy: 1) For estimates of the effects of measured risk factors on the outcome, adjustment for the covariate infection should not be done; this will avoid problems of overadjustment. 2) After control for the measured risk factors, an estimate of the "effect" of the covariate infection may be used as an indicator of the presence of unmeasured shared risk factors. 3) When shared, measured risk factors exist, the authors propose the use of methods developed for analysis of repeated measures of categorical variables to assist in inference about shared mechanisms of action of these risk factors. This analytic strategy takes advantage of the method of analogy for building understanding of transmission of new agents through their parallels with better known ones and is useful in the development of hypotheses.
Collapse
Affiliation(s)
- A A Evans
- Department of Epidemiology, Harvard School of Public Health, Boston, MA
| | | | | |
Collapse
|
29
|
Katkov WN, Dienstag JL, Cody H, Evans AA, Choo QL, Houghton M, Kuo G. Role of hepatitis C virus in non-B chronic liver disease. Arch Intern Med 1991; 151:1548-52. [PMID: 1651689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
To assess the contribution of the recently identified hepatitis C virus to chronic liver diseases of unknown cause and chronic hepatitis attributed by exclusion to non-A, non-B hepatitis, we tested for antibody to hepatitis C in hepatitis B surface antigen-negative patients with a spectrum of chronic liver diseases. Antibody to hepatitis C virus, a marker of hepatitis C infection, was detected with a first-generation radioimmunoassay at the following frequencies in the following patient groups: 69% of transfusion-associated non-A, non-B hepatitis; 53% of non-transfusion-associated non-A, non-B hepatitis; 26% of hepatitis B surface antigen-negative hepatocellular carcinoma; 8% of cryptogenic cirrhosis; 5% to 7% of autoimmune chronic liver diseases; 19% of patients with miscellaneous types of chronic liver disease; and 0.67% of healthy controls. Among non-transfusion-associated cases, 81% with a history of intravenous drug use but only 18% with occupational exposure as health workers had antibody to hepatitis C virus. Among cases of hepatocellular carcinoma, 63% of Japanese patients but only 11% of American patients had evidence of hepatitis C infection. Comparison in a subgroup of 79 serum samples of a second-generation radioimmunoassay with the first-generation assay demonstrated a 12% increase in antibody frequency from 30% to 42%. We conclude that hepatitis C plays a substantial role in transfusion-associated and non-transfusion-associated non-A, non-B hepatitis as well as in hepatocellular carcinoma, especially in Japan, a limited role in cryptogenic cirrhosis, and essentially no role in autoimmune chronic liver diseases. Application of more sensitive immunoassays will increase the frequency of antibody seropositivity in all subgroups, but relative distinctions among risk groups are likely to remain.
Collapse
Affiliation(s)
- W N Katkov
- Medical Services (Gastrointestinal Unit), Massachusetts General Hospital, Boston 02114
| | | | | | | | | | | | | |
Collapse
|
30
|
Abstract
To examine the effect of preoperative total parenteral nutrition (TPN) on patients with Crohn's disease undergoing bowel resection, an historical cohort was assembled of 103 patients resected between 1982 and 1984 by a single surgical team. Preoperative, perioperative, and postoperative variables were compared between patients receiving TPN and patients not receiving TPN. Analysis was stratified for three surgical procedures: segmental small bowel resection, ileocectomy, and segmental or total colectomy The effect of TPN was most pronounced in patients having small bowel surgery. For segmental small bowel resection, 12 of 17 patients had TPN, and these patients had 20.4 +/- 14.3 cm less bowel resected than did those in the non-TPN group, an effect not dependent on duration of TPN. For ileocectomy patients, 31 of 62 patients received TPN, and these patients had 11.2 +/- 4.2 cm less small bowel resected than the non-TPN group, an effect not dependent on the duration of TPN. For large bowel resection patients, 6 of 24 patients had TPN, and there was no difference in length of bowel resection, preoperative and perioperative variables, or recurrence. The total hospital stay was 13.5 +/- 2.6 days longer for those having TPN; 3.5 +/- 1.9 days of the longer stay was postoperative. In conclusion, TPN was associated with reduced length of small bowel resection at the expense of longer hospital stay.
Collapse
Affiliation(s)
- B A Lashner
- Section of Gastroenterology, University of Chicago Medical Center, Illinois 60637
| | | | | |
Collapse
|
31
|
Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB. Cigarette smoking in Crohn's disease. Am J Gastroenterol 1989; 84:31-3. [PMID: 2912028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Crohn's disease is a chronic disease of unknown etiology. Previous reports have suggested that cigarette smoking may be associated with the development of Crohn's disease. To examine this association, we conducted a case-control study of patients referred to a single practice over a 7-month period. The cigarette-smoking habits of 115 patients with Crohn's disease were compared with the cigarette-smoking exposure of 109 patients with the irritable bowel syndrome. Patients with Crohn's disease were more likely to smoke at the time of symptom onset than were irritable bowel syndrome controls (age and sex adjusted odds ratio 3.71, 95% confidence interval 1.93-7.13). After the diagnosis of Crohn's disease, patients were less likely to quit smoking (odds ratio 0.35, 95% confidence interval 0.18-0.69) than controls. This study demonstrates an association and a temporal relationship between cigarette smoking and Crohn's disease. For the exposure to be considered an etiologic factor for disease, biologic plausibility and pathophysiologic mechanisms require elucidation.
Collapse
Affiliation(s)
- M D Silverstein
- Department of Medicine, University of Chicago Medical Center, Illinois
| | | | | | | | | |
Collapse
|
32
|
Abstract
PURPOSE Chronic hepatitis is known to be a disease with substantial mortality. The purpose of this study was to identify prognostic factors in a large group of patients with chronic hepatitis. We also wanted to determine whether the aminopyrine breath test (ABT) is of additional prognostic value in evaluation of this disease. PATIENTS AND METHODS We studied 94 patients who had had a biopsy-proven diagnosis and an ABT between June 1, 1977, and June 30, 1981. Clinical features and biochemical test results at the time of diagnosis were retrieved from medical records, and histologic severity was assessed by reviewing all liver biopsy specimens under code. Survival was determined at a mean of 60 months. Data were studied with a Cox proportional hazards model to identify predictors of mortality and to control for confounding variables. RESULTS Cumulative mortality as of December 31, 1985, was 5 percent in chronic persistent hepatitis, 6 percent in chronic active hepatitis, 29 percent in chronic active hepatitis with bridging necrosis, and 53 percent in chronic active hepatitis with cirrhosis. Histologic severity was a predictor of death (p less than 0.005). Other predictors of mortality were disease caused by hepatitis B virus (p less than 0.005), a high alkaline phosphatase level (p less than 0.025), a low alanine aminotransaminase level (p less than 0.001), and a depressed ABT result (p less than 0.005). CONCLUSION The results suggest that patients with chronic hepatitis with one or more of these risk factors have an increased mortality and should be followed closely for liver failure, which may necessitate medical therapy or surgical intervention.
Collapse
Affiliation(s)
- B A Lashner
- Liver Study Unit, University of Chicago Medical Center, Illinois 60637
| | | | | | | | | | | |
Collapse
|
33
|
Abstract
To determine the risk of having or developing inflammatory bowel disease (IBD) in a family member of an IBD patient, a population of 245 IBD probands was randomly selected from the University of Chicago IBD Registry and their family history was elucidated by questionnaire and follow-up telephone call. One hundred seventy-nine (73%) probands responded to the questionnaire. There were no demographic distinctions between those eligible for the study, those who were complete responders, those who were nonresponders, and those with a positive family history of IBD. Fifty-four family members from 40 proband families (22%) had confirmed IBD. Prevalence of IBD in family members at the time of diagnosis of the proband was highest for parents (4.6%), siblings (2.6%), and children (1.9%). Grandparents, aunts and uncles, and first cousins had prevalence of IBD of less than 1%. Incident case frequency was determined by dividing the number of cases incident after the diagnosis of the proband by all those ever at risk. The incident case frequency was highest for siblings (1.9%), parents (1.0%), and children (1.0%). There was concordance noted for type of disease in the proband and the relative. No association could be discerned between the familial risk of IBD and gender, race, or religion of the proband. Despite a high occurrence rate of proband families with IBD, the specific risk to first, second, or third degree family members is low.
Collapse
|
34
|
Mendis AH, Evans AA. Substrates respired by mitochondrial fractions of two isolates of the nematode Aphelenchus avenae and the effects of electron transport inhibitors. Comp Biochem Physiol B 1984; 78:373-8. [PMID: 6088169 DOI: 10.1016/0305-0491(84)90045-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
Electron transport has been assayed and compared in two isolates (M and F) of the free-living (model) nematode Aphelenchus avenae. Of the substrates tested only alpha-glycerophosphate and succinate were utilised to any significant extent by both isolates. Comparative data on respiratory rates, respiratory control ratios and ADP:O ratios for various substrates are given. Succinate oxidation by isolate-F mitochondria was ca 80-90% sensitive to antimycin A while that of isolate M was almost completely refractory to antimycin A. The response to other electron transport inhibitors suggests the operation of (a) azide/cyanide sensitive, (b) azide/salicylhydroxamic acid (SHAM) insensitive but carbon monoxide sensitive and (c) SHAM-sensitive terminal oxidases to varying degrees in the mitochondria of these two isolates of A. avenae.
Collapse
|
35
|
Solomon KR, Evans AA. The activity of insect juvenile hormone mimics in larval Amblyomma hebraeum Koch (Acarina: Metastriata: Ixodidae). Onderstepoort J Vet Res 1978; 45:39-41. [PMID: 704043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
A total of 14 insect juvenile hormone mimics was tested for activity in Amblyomma hebraeum by exposing newly engorged larvae to filter paper impregnated with hormone mimics. The most active compounds used in this assay were HS 103 (6-ethyl-3-pyridyl geranyl ether; EC50=0,0018 mg/cm2), ZR 512 (Ethyl 3,7,11-trimethyldodeca-2,4-dienoate; EC50=0,0022 mg/cm2), HS 2 (6-methyl-3-pyridyl geranyl ether; EC50=0,0035 mg/cm2), ZR 615 (N-ethyl 3,7,11-trimethyldodeca-2,4-dieneamide; EC50=0,0035 mg/cm2), ZR 777 (Prop-2-ynyl 3,7,11-trimethyldodeca-2,4-dienoate; EC50=0,0039 mg/cm2) and ZR 515 (Isopropyl-11-methoxy 3,7,11-trimethyldodeca-2,4-dienoate; EC50=0,0094 mg/cm2). Activity in this assay was similar to that reported in insects and was consistent with the susceptibility of these compounds to metabolic inactivation. The results suggest that ZR 615 may be of possible use in tick control.
Collapse
|
36
|
Evans AA, Solomon KR. Neurosecretion in Ornithodoros savignyi (Audouin) (Ixodoidea: Argasidae). The distribution of neurosecretory cells in the brain. Onderstepoort J Vet Res 1977; 44:127-30. [PMID: 614529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
The arrangement of the brain and peripheral nerves in Ornithodoros savignyi (Audouin) is similar to that of other argasid and ixodid ticks. Histological studies, using a specialized staining technique (aldehyde fuchsin), have shown 15 groups of neurosecretory cells in the cortex of the brain.
Collapse
|
37
|
|
38
|
Evans AA, Fisher JM. The Excretory Systems of Three Ditylenchus spp. J Nematol 1970; 2:260-264. [PMID: 19322308 PMCID: PMC2618739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023] Open
Abstract
In Ditylenchus dipsaci the morphologically different anterior and posterior regions of the terminal excretory duct are separated by a constriction. Immediately posterior to the constriction is a valve-like structure composed of dense pieces integral with the wall of the duct. The posterior region is sometimes dilated at intervals along its length. The same structures are present in D. myceliophagus and D. destructor, but the dense pieces appear less well developed. A possible mode of action for the excretory system is discussed.
Collapse
|
39
|
Evans AA. Mass culture of mycophagous nematodes. J Nematol 1970; 2:99-100. [PMID: 19322278 PMCID: PMC2618716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023] Open
|